A simple HPLC method for quantitation of repaglinide in tablet dosage form

Indian Drugs

Volumn 44, Issue 6, 2007, Pages 428-433

  Khan, R H ^a   Talegaonkar, S ^a   Singh, R M ^a   Mathur, S C ^a   Raj, Shiv ^a   Singh, G N ^a  

^a Central Indian Pharmacopoeia Laboratory   (India)

Author keywords

HPLC; Repaglinide; Tablets

Indexed keywords

EID: 77949905842     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bidstrup T.B., Bijornsdottir I, Siddelmann UG, Thomsen MS Hansen KT, "CYPZ C8 and CYPA4 are the principle enzymes involved in the human in-vitro biotransformation of the insulin scretagogue repaglinide". Br J Clin Pharmacol, 2003, Sep, 56(3): 305-14.
2. Jamil S., Ansari T.A., Singh R.M., Mathur S.C., Nivoria S.C., Pandey M., Singh G.N. "Determination of Rosuvastatin Calcium in pharmaceutical dosage form by RP-HPLC method" Indian Drugs, 2005, 42 (2): 98-101.
3. Ho En, Yiu K.C., Wan T.S., Stewart B.D., Watkins K.L. "Detection of anti-diabetics in equine plasma and urine by liquid chromatography- tandem mass spectroscopy". J Chromatrogr B Analyt Technol Biomed Life Sci, 2004 Nov 5, 811(1): 65-73. (Pubitemid 39348851)
4. Reddy K.V., Babu J.M., Mathad V.T., Eswaraiah S., Reddy M.S., Dubey P.K., Vyas K. "Impurities profile study of repaglinide". J Pharm Biomed Ana, 2003, Jul 14, 32 (3): 461-467.
5. Zhang Y., Zhou J., Corll C., Porter J.R., Martin R.J., Roane D.S. "Evidence for hypothalamic K+(ATP) channels in the modulation of glucose homeostasis". Eur J Pharmacol, 2004 May10, 49 (1): 71-79. (Pubitemid 38624425)
6. P.D. Sethi "HPLC quantitative analysis of pharmaceutical formulation" Fifth edition, by CBS publication, pg.no. 11-160.
7. M. Zaxariou, I. Panderi "Development and validation of a HPLC method for the determination of buspirone in pharmaceutical preprations" J Pharm Biomed Anal, 2004 Dec, 35: 41-50. (Pubitemid 38368858)
8. th Edition, Volume 1, pg.no, 603-05, 618-620.
9. Grieschel A., Beschke K., Rapp H. Roth W. "Quantification of the new hypoglycemic agent AG-EE388 in human plasma" J Pharm Bio Med Anal, 2004 May, 36(2): 591-597.
10. International Confrence on Harmonization, draft guideline on validation procedure, definition and terminology federal register. 1995, 60: 11260.